Market Tracker

05/26 5:16pm ET

Perrigo Company PLC (NYSE:PRGO)

69.95
Delayed Data
As of May 26
 -1.90 / -2.64%
Today’s Change
65.47
Today|||52-Week Range
111.00
-15.96%
Year-to-Date
PRGO Regular Dividend: PRGO began trading ex-dividend on 05/24/17. A $0.16 dividend will be paid to shareholders of record as of 05/26/17.
Perrigo, Taro Show Perils of Failure to Branch in Branded Drugs
May 23 / TheStreet.com - Paid Partner Content
Beware of Selling Naked Puts (Part Deux)
May 23 / TheStreet.com - Paid Partner Content
Here's a Case Where You Might Want to Get Naked
May 23 / TheStreet.com - Paid Partner Content
Investors keep calm; Trump's budget; Take-Two tumbles
May 23 / CNNMoney.com

Today’s Trading

Previous close71.85
Today’s open71.92
Day’s range69.84 - 71.92
Volume1,724,938
Average volume (3 months)1,954,462
Market cap$10.3B
Dividend yield0.91%
Data as of 4:01pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-95.67%
Earnings growth (this year)--
Earnings growth (next 5 years)+2.90%
Revenue growth (last year)+36.36%
P/E ratio14.8
Price/Sales3.82
Price/Book1.02

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc-0.45-0.68%
JAZZJazz Pharmaceuticals...-0.94-0.62%
ALKSAlkermes Plc-0.24-0.41%
TSROTESARO Inc-4.08-2.66%
Data as of 3:59pm ET, 05/26/2017

Financials

Next reporting dateMay 29, 2017
EPS forecast (this quarter)$0.98
Annual revenue (last year)$5.5B
Annual profit (last year)$11.2M
Net profit margin0.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
John T. Hendrickson
Chief Financial Officer
Ron L. Winowiecki
Corporate headquarters
Dublin, Dublin

Forecasts